ACRUX LTD.

Research ACRUX LTD. (FJY) on Bullrun: market cap EUR 1.57M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerFJY
• ExchangeF
• CountryAustralia
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 1.57M
• Financial periodFY2025
• RevenueEUR 1.19M
• Revenue growth-76.6%
• Net income-EUR 5.95M
• Free cash flow-EUR 5.48M
• Gross margin100.0%

Valuation Snapshot

latest market cap is EUR 1.57M.

About ACRUX LTD.

Acrux Limited, together with its subsidiaries, develops and commercializes generic and topically applied pharmaceutical products in Australia, Europe, the United States, and internationally. The company provides estradiol transdermal sprays to women for the treatment of flushes associated with menopause under the Evamist and Lenzetto brand names; Dapsone 5% and Dapsone 7.5%, which are gels for the treatment of acne vulgaris; and Lidocaine and Prilocaine Cream USP, a topical anesthetic cream.

Frequently asked questions

What is ACRUX LTD.'s market cap?

ACRUX LTD.'s market capitalization is EUR 1.57M.

What does ACRUX LTD. do?

Acrux Limited, together with its subsidiaries, develops and commercializes generic and topically applied pharmaceutical products in Australia, Europe, the United States, and internationally.